Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma

Inclusion Criteria: * Patients with HCC diagnosed by histology or by imaging findings according to the Barcelona Clinic Liver Cancer Group * Patients with a single or multiple HCCs deemed to be resectable with a curative intent at the preoperative evaluation * Patients for whom an indication for hepatectomy has been decided and approved by multidisciplinary board: * by laparotomy * by coelioscopy with resection of at least 2 liver segments * Patients with any underlying liver disease with or without proven cirrhosis, regarding histological features (including F2-F3-F4 fibrosis with or without cirrhosis) or with other evidence of a diseased liver if no biopsy has been performed preoperatively (dysmorphic liver or evidence of portal hypertension at imaging findings, oesophageal varices at endoscopy) * Age ≥ 18 years * Patients with ability to understand and sign a written inform consent form * Patients who will be available for follow-up Exclusion Criteria: * Patients participating in another interventional research in progress or including an exclusion period still in progress at pre-inclusion (except interventional research with minimal risks and constraints that do not interfere with the judgement criteria of the study according to the judgement of the coordinating investigator). * Patients with evidence of a healthy liver at biopsy Disease-associated non-inclusion criteria include: * Another histologic type of hepatic tumor besides HCC * Distant extra-hepatic metastases, including peritoneal carcinomatosis * The existence of complete portal thrombosis of the main portal trunk Operative technique-associated non-inclusion criteria include: \- Indication of coelioscopy with resection of less than 2 liver segments